These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 17412431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B.
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L.
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [Abstract] [Full Text] [Related]

  • 5. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [Abstract] [Full Text] [Related]

  • 6. FXR: a metabolic regulator and cell protector.
    Wang YD, Chen WD, Moore DD, Huang W.
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [Abstract] [Full Text] [Related]

  • 7. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
    Duran-Sandoval D, Cariou B, Fruchart JC, Staels B.
    Biochimie; 2005 Jan; 87(1):93-8. PubMed ID: 15733743
    [Abstract] [Full Text] [Related]

  • 8. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control.
    Kuipers F, Stroeve JH, Caron S, Staels B.
    Curr Opin Lipidol; 2007 Jun; 18(3):289-97. PubMed ID: 17495603
    [Abstract] [Full Text] [Related]

  • 9. Effects of coumestrol on lipid and glucose metabolism as a farnesoid X receptor ligand.
    Takahashi M, Kanayama T, Yashiro T, Kondo H, Murase T, Hase T, Tokimitsu I, Nishikawa J, Sato R.
    Biochem Biophys Res Commun; 2008 Aug 01; 372(3):395-9. PubMed ID: 18457666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.
    Fiorucci S, Cipriani S, Baldelli F, Mencarelli A.
    Prog Lipid Res; 2010 Apr 01; 49(2):171-85. PubMed ID: 19932133
    [Abstract] [Full Text] [Related]

  • 16. 5Alpha-bile alcohols function as farnesoid X receptor antagonists.
    Nishimaki-Mogami T, Kawahara Y, Tamehiro N, Yoshida T, Inoue K, Ohno Y, Nagao T, Une M.
    Biochem Biophys Res Commun; 2006 Jan 06; 339(1):386-91. PubMed ID: 16300737
    [Abstract] [Full Text] [Related]

  • 17. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor.
    Howard WR, Pospisil JA, Njolito E, Noonan DJ.
    Toxicol Appl Pharmacol; 2000 Mar 01; 163(2):195-202. PubMed ID: 10698678
    [Abstract] [Full Text] [Related]

  • 18. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries.
    Nicolaou KC, Evans RM, Roecker AJ, Hughes R, Downes M, Pfefferkorn JA.
    Org Biomol Chem; 2003 Mar 21; 1(6):908-20. PubMed ID: 12929628
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist.
    Kainuma M, Makishima M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem; 2007 Apr 01; 15(7):2587-600. PubMed ID: 17292610
    [Abstract] [Full Text] [Related]

  • 20. FXR, a multipurpose nuclear receptor.
    Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y.
    Trends Biochem Sci; 2006 Oct 01; 31(10):572-80. PubMed ID: 16908160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.